Health sciences researchers from around the globe will gather in Buffalo for the 18th Annual Conference for Administrators of Awards from the Fogarty International Center hosted by the University at Buffalo Center for Integrated Global Biomedical Sciences.
A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss, nerve damage and other symptoms of Alzheimer’s disease.
BUFFALO, N.Y.—Joseph Balthasar, professor of pharmaceutical sciences, was appointed Executive Director of Research Initiatives in the Office of the Vice President for Research and Economic Development at the University at Buffalo.
One hundred and thirty-three students will take their first step toward becoming pharmacists when they participate in the University at Buffalo School of Pharmacy and Pharmaceutical Sciences Annual White Coat Ceremony.
BUFFALO, N.Y. — The University at Buffalo Center for Protein Therapeutics has awarded over $1 million for research projects to advance the development of next-generation protein drugs for the 2019-2020 academic year.
Higher levels of blood high-density lipoprotein (HDL) — or good cholesterol — may improve fatigue in multiple sclerosis patients, according to a new UB-led study.
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences now offers an innovative new master’s degree program in Pharmacometrics and Personalized Pharmacotherapy.
BUFFALO, NY--The University at Buffalo School of Pharmacy and Pharmaceutical Sciences hosted students, scientists and researchers from around the world for two pharmaceutical sciences meetings: the Quantitative Systems Pharmacology Symposium and the Great Lakes Symposium.
William Jusko, SUNY Distinguished Professor of Pharmaceutical Sciences, has received a five-year MIRA award totaling nearly $2.9 million for research entitled “Mechanistic Pharmacokinetics and Pharmacodynamics.”
